Oligosaccharides from human milk induce growth arrest via G2/M by influencing growth-related cell cycle genes in intestinal epithelial cells

British Journal of Nutrition

Volumn 101, Issue 9, 2009, Pages 1306-1315

  Kuntz, Sabine ^a   Kunz, Clemens ^a   Rudloff, Silvia ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Cyclin dependent kinase inhibitors; Cyclins; G2 M arrest; Mitogen activated protein kinase signalling; Oligosaccharides

Indexed keywords

CYCLIN A; CYCLIN B; CYCLIN D; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN E; EPIDERMAL GROWTH FACTOR RECEPTOR; HUMAN MILK OLIGOSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; OLIGOSACCHARIDE; PROTEIN P53; UNCLASSIFIED DRUG; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLINE; TUMOR SUPPRESSOR PROTEIN;

ACIDITY; ARTICLE; BREAST MILK; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL DIFFERENTIATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; NUCLEOTIDE SEQUENCE; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; BIOSYNTHESIS; CARBOHYDRATE DIET; CELL CYCLE; CELL PROLIFERATION; CHEMISTRY; CYTOLOGY; DRUG EFFECT; GENE; GENE EXPRESSION REGULATION; GENETICS; INTESTINE MUCOSA; METABOLISM; METHODOLOGY; TUMOR CELL CULTURE;

CELL CYCLE; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR PROTEINS; CYCLINS; DIETARY CARBOHYDRATES; GENE EXPRESSION REGULATION; GENES, CDC; HUMANS; INTESTINAL MUCOSA; MILK, HUMAN; OLIGOSACCHARIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 67649366235     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114508079622     Document Type: Article

References (42)

1. Sharon N & Ofek I (2000) Safe as mother's milk: Carbohydrates as future anti-adhesion drugs for bacterial diseases. Glycoconj J 17, 659-664.
2. Kunz C, Rudloff S, Baier W, Klein N & Strobel S (2000) Oligosaccharides in human milk: Structural, functional, and metabolic aspects. Annu Rev Nutr 20, 699-722.
3. Bode L, Kunz C, Muhly-Reinholz M, Mayer K, Seeger W & Rudloff S (2004) Inhibition of monocyte, lymphocyte, and neutrophil adhesion to endothelial cells by human milk oligosaccharides. Thromb Haemost 92, 1402-1410.
4. Bode L, Rudloff S, Kunz C, Strobel S & Klein N (2004) Human milk oligosaccharides reduce platelet-neutrophil complex formation leading to a decrease in neutrophil β2 integrin expression. J Leukocyte Biol 76, 1-7.
5. Kobata A & Ginsburg V (1972) Oligosaccharides of human milk. 3. Isolation and characterization of a new hexasaccharide, lacto-N hexaose. J Biol Chem 247, 1525-1529.
6. Kobata A, Yamashita K & Tachibana Y (1978) Oligosaccharides from human milk. Methods Enzymol 50, 216-220.
7. Kunz C, Rudloff S, Hintelmann A, Pohlentz G & Egge H (1996) High-pH anion-exchange chromatography with pulsed amperometric detection and molar response factors of human milk oligosaccharides. J Chromatogr B Biomed Appl 25, 211-221.
8. Parkkinen J & Finne J (1987) Isolation of sialyl oligosaccharides and sialyl oligosaccharide phosphates from bovine colostrum and human urine. Methods Enzymol 138, 289-300.
9. Kunz C & Rudloff S (2000) Oligosaccharides in human milk: Structural, functional and metabolic aspects. Annu Rev Nutr 20, 699-722.
10. Engfer MB, Stahl B, Finke B, Sawatzki G & Daniel H (2000) Human milk oligosaccharides are resistant to enzymatic hydrolysis in the upper gastrointestinal tract. Am J Clin Nutr 71, 1589-1596.
11. Gnoth MJ, Kunz C, Kinne-Saffran E & Rudloff S (2000) Human milk oligosaccharides are minimally digested in vitro. J Nutr 130 3014-3020.
12. Gnoth MJ, Rudloff S, Kunz C & Kinne RK (2001) Investigations of the in vitro transport of human milk oligosaccharides by a Caco-2 monolayer using a novel high performance liquid chromatography-mass spectrometry technique. J Biol Chem 14, 34363-34370.
13. Kuntz S, Rudloff S & Kunz C (2008) Oligosaccharides from human milk influence growth-related characteristics of intestinally transformed and non-transformed intestinal cells. Br J Nutr 99, 462-471.
14. Vermeulen K, Van Bockstaele DR & Berneman ZN (2003) The cell cycle: A review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif 36, 131-149.
15. Serrano M (2003) Proliferation: The cell cycle. Adv Exp Med Biol 532, 13-17.
16. Stein GH & Dulic V (1998) Molecular mechanisms for the senescent cell cycle arrest. J Investig Dermatol Symp Proc 3, 14-18.
17. Dai Y & Grant S (2003) Cyclin-dependent kinase inhibitors. Curr Opin Pharmacol 3, 362-370.
18. Mani S, Wang C, Wu K, Francis R & Pestell R (2000) Cyclin-dependent kinase inhibitors: Novel anticancer agents. Expert Opin Investig Drugs 9, 1849-1870.
19. Baghdassarian N & French M (1996) Cyclin-dependent kinase inhibitors (CKIs) and hematological malignancies. Hematol Cell Ther 38, 152-158.
20. Li Y, Dowbenko D & Lasky L (2002) AKT/PKB phosphorylation of p21Cip/WAF1 enhances protein stability of p21Cip/WAF1 and promotes cell survival. J Biol Chem 17, 277-286.
21. 13C-galactose into milk lactose and oligosaccharides. Glycobiology 16, 477-487.
22. Perreault N & Beaulieu JF (1996) Use of the dissociating enzyme thermolysin to generate viable human normal intestinal epithelial cell cultures. Exp Cell Res 1, 354-364.
23. Nadella KS & Kirschner LS (2005) Disruption of protein kinase A regulation causes immortalization and dysregulation of D-type cyclins. Cancer Res 15, 10307-10315.
24. Ouyang W, Ma Q, Li J, Zhang D, Liu ZG, Rustgi AK & Huang C (2005) Cyclin D1 induction through IkappaB kinase beta/nuclear factor-kappaB pathway is responsible for arsenite-induced increased cell cycle G1-S phase transition in human keratinocytes. Cancer Res 15, 9287-9293.
25. Lewis RC, Bostick RM, Xie D, Deng Z, Wargovich MJ, Fina MF, Roufail WM & Geisinger KR (2003) Polymorphism of the cyclin D1 gene, CCND1, and risk for incident sporadic colorectal adenomas. Cancer Res 63, 8549-8553.
26. McKay JA, Douglas JJ, Ross VG, Curran S, Murray GI, Cassidy J & McLeod HL (2000) Cyclin D1 protein expression and gene polymorphism in colorectal cancer. Int J Cancer 88, 77-81.
27. Dash BC & El-Deiry WS (2005) Phosphorylation of p21 in G2/M promotes cyclin B-Cdc2 kinase activity. Mol Cell Biol 25, 3364-3387.
28. Ji P, Agrawal S, Diederichs S, et al. (2005) Cyclin A1, the alternative A-type cyclin, contributes to G1/S cell cycle progression in somatic cells. Oncogene 14, 2739-2744.
29. Li R, Hannon GJ, Beach D & Stillman B (1996) Subcellular distribution of p21 and PCNA in normal and repair-deficient cells following DNA damage. Curr Biol 6, 189-199.
30. Harper JW, Elledge SJ, Keyomarsi K, et al. (1995) Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell 6, 387-400.
31. Sherr CJ & Roberts JM (1999) CDK inhibitors: Positive and negative regulators of G1-phase progression. Genes Dev 13, 1501-1512.
32. Blain SW, Montalvo E & Massagué J (1997) Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4. J Biol Chem 272, 25863-25872.
33. Matsui TA, Sowa Y, Murata H, et al. (2007) The plant alkaloid cryptolepine induces p21WAF1/CIP1 and cell cycle arrest in a human osteosarcoma cell line. Int J Oncol 31, 915-922.
34. Sowa Y, Murata H, Takagi K, et al. (2007) The plant alkaloid cryptolepine induces p21WAF1/CIP1 and cell cycle arrest in a human osteosarcoma cell line. Int J Oncol 31, 915-922.
35. Aoki S, Kong D, Suna H, Sowa Y, Sakai T, Setiawan A & Kobayashi M (2006) Aaptamine, a spongean alkaloid, activates p21 promoter in a p53-independent manner. Biochem Biophys Res Commun 342, 101-116.
36. Tarnawski AS & Jones MK (1998) The role of epidermal growth factor (EGF) and its receptor in mucosal protection, adaptation to injury, and ulcer healing: Involvement of EGF-R signal transduction pathways. J Clin Gastroenterol 27, S12-S20.
37. Sundaram MV (2006) RTK/Ras/MAPK signaling. WormBook 11, 1-19.
38. 3-induced c-Src/EGFR/ERK signaling is via Sp1 binding sites to stimulate p21WAF1/CIP1 expression in human epidermoid carcinoma A431 cells. Cell Signal 18, 244-255.
39. Matsumoto E, Hatanaka M, Bohgaki M & Maeda S (2006) PKC pathway and ERK/MAPK pathway are required for induction of cyclin D1 and p21Waf1 during 12-o-tetradecanoylphorbol 13-acetate-induced differentiation of myeloleukemia cells. Kobe J Med Sci 52, 181-194.
40. Kuwahara I, Lillehoj EP, Lu W, Singh IS, Isohama Y, Miyata T & Kim KC (2006) Neutrophil elastase induces IL-8 gene transcription and protein release through p38/NF-kB activation via EGFR transactivation in a lung epithelial cell line. Am J Physiol Lung Cell Mol Physiol 291 407-416.
41. Matsuo M, Sakurai H, Ueno Y, Ohtani O & Saiki I (2006) Activation of MEK/ERK and PI3K/Akt pathways by fibronectin requires integrin alphav-mediated ADAM activity in hepatocellular carcinoma: A novel functional target for gefitinib. Cancer Sci 97, 155-162.
42. Xu K & Shu HK (2007) EGFR activation results in enhanced cyclooxygenase-2 expression through p38 mitogen-activated protein kinase-dependent activation of the Sp1/Sp3 transcription factors in human gliomas. Cancer Res 67, 6121-6129.